Spire Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-800
Closed -$3.1K 2343
2026
Q1
$3.1K Hold
800
﹤0.01% 1948
2025
Q4
$3.34K Hold
800
﹤0.01% 1988
2025
Q3
$2.63K Hold
800
﹤0.01% 2107
2025
Q2
$1.14K Hold
800
﹤0.01% 2259
2025
Q1
$1.19K Sell
800
-600
-43% -$945 ﹤0.01% 2360
2024
Q4
$1.57K Buy
1,400
+2
+0.1% +$2 ﹤0.01% 2296
2024
Q3
$1.33K Sell
1,398
-2
-0.1% -$3 ﹤0.01% 2063
2024
Q2
$2.21K Hold
1,400
﹤0.01% 1994
2024
Q1
$2.03K Hold
1,400
﹤0.01% 2092
2023
Q4
$1.79K Hold
1,400
﹤0.01% 2164
2023
Q3
$1.99K Hold
1,400
﹤0.01% 2140
2023
Q2
$1.61K Hold
1,400
﹤0.01% 2230
2023
Q1
$1.48K Hold
1,400
﹤0.01% 2323
2022
Q4
$2K Hold
1,400
﹤0.01% 2085
2022
Q3
$3K Buy
1,400
+600
+75% +$1.26K ﹤0.01% 1882
2022
Q2
$1K Hold
800
﹤0.01% 2563
2022
Q1
$2K Hold
800
﹤0.01% 2410
2021
Q4
$3K Hold
800
﹤0.01% 2710
2021
Q3
$4K Hold
800
﹤0.01% 2351
2021
Q2
$5K Sell
800
-200
-20% -$1.4K ﹤0.01% 2320
2021
Q1
$7K Buy
+1,000
New +$8.45K ﹤0.01% 2537

Other funds holding PGEN

Spire Wealth Management's PGEN Position: Q2 2026 in Review

Spire Wealth Management sold out of Precigen (PGEN) in Q2 2026, closing a stake of 800 shares — an estimated $3.1K sold.

Spire Wealth Management first reported a position in PGEN in Q1 2021 and held it in 21 quarters. The position peaked at $7K in Q1 2021. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Spire Wealth Management reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Spire Wealth Management sold 800 Precigen shares in Q2 2026, an estimated $3.1K.
  • Spire Wealth Management first reported a position in Precigen in Q1 2021 and held it in 21 quarters.
  • Spire Wealth Management's Precigen position peaked at $7K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.